» Articles » PMID: 27043316

CD34 Expression Modulates Tube-forming Capacity and Barrier Properties of Peripheral Blood-derived Endothelial Colony-forming Cells (ECFCs)

Overview
Journal Angiogenesis
Publisher Springer
Specialty Hematology
Date 2016 Apr 5
PMID 27043316
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial colony-forming cells (ECFC) are grown from circulating CD34(+) progenitors present in adult peripheral blood, but during in vitro expansion part of the cells lose CD34. To evaluate whether the regulation of CD34 characterizes the angiogenic phenotypical features of PB-ECFCs, we investigated the properties of CD34(+) and CD34(-) ECFCs with respect to their ability to form capillary-like tubes in 3D fibrin matrices, tip-cell gene expression, and barrier integrity. Selection of CD34(+) and CD34(-) ECFCs from subcultured ECFCs was accomplished by magnetic sorting (FACS: CD34(+): 95 % pos; CD34(-): 99 % neg). Both fractions proliferated at same rate, while CD34(+) ECFCs exhibited higher tube-forming capacity and tip-cell gene expression than CD3(4-) cells. However, during cell culture CD34(-) cells re-expressed CD34. Cell-seeding density, cell-cell contact formation, and serum supplements modulated CD34 expression. CD34 expression in ECFCs was strongly suppressed by newborn calf serum. Stimulation with FGF-2, VEGF, or HGF prepared in medium supplemented with 3 % albumin did not change CD34 mRNA or surface expression. Silencing of CD34 with siRNA resulted in strengthening of cell-cell contacts and increased barrier function of ECFC monolayers as measured by ECIS. Furthermore, CD34 siRNA reduced tube formation by ECFC, but did not affect tip-cell gene expression. These findings demonstrate that CD34(+) and CD34(-) cells are different phenotypes of similar cells and that CD34 (1) can be regulated in ECFC; (2) is positively involved in capillary-like sprout formation; (3) is associated but not causally related to tip-cell gene expression; and (4) can affect endothelial barrier function.

Citing Articles

Immune-privileged cord blood-derived endothelial colony-forming cells: advancing immunomodulation and vascular regeneration.

Smadja D, Berkane Y, Bentounes N, Rancic J, Cras A, Pinault C Angiogenesis. 2025; 28(2):19.

PMID: 40047974 PMC: 11885380. DOI: 10.1007/s10456-025-09973-9.


CD34+ synovial fibroblasts exhibit high osteogenic potential in synovial chondromatosis.

Li X, Sun H, Li D, Cai Z, Xu J, Ma R Cell Tissue Res. 2024; 397(1):37-50.

PMID: 38602543 DOI: 10.1007/s00441-024-03892-9.


Endothelial CD34 expression and regulation of immune cell response in-vitro.

Arakelian L, Lion J, Churlaud G, Bargui R, Thierry B, Mutabazi E Sci Rep. 2023; 13(1):13512.

PMID: 37598252 PMC: 10439936. DOI: 10.1038/s41598-023-40622-7.


Extracellular vesicles engineering by silicates-activated endothelial progenitor cells for myocardial infarction treatment in male mice.

Yu B, Li H, Zhang Z, Chen P, Wang L, Fan X Nat Commun. 2023; 14(1):2094.

PMID: 37055411 PMC: 10102163. DOI: 10.1038/s41467-023-37832-y.


Increased CD34 in pancreatic islet negatively predict islet β-cell decrease in type1 diabetes model.

Huang S, Li Z, Sun Y, Chen B, Jiang Y, Hong F Front Physiol. 2022; 13:1032774.

PMID: 36467676 PMC: 9716098. DOI: 10.3389/fphys.2022.1032774.


References
1.
Stella C, Cazzola M, de Fabritiis P, De Vincentiis A, Gianni A, Lanza F . CD34-positive cells: biology and clinical relevance. Haematologica. 1995; 80(4):367-87. View

2.
Tasev D, Van Wijhe M, Weijers E, van Hinsbergh V, Koolwijk P . Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity. PLoS One. 2015; 10(6):e0129935. PMC: 4468160. DOI: 10.1371/journal.pone.0129935. View

3.
Aman J, van Bezu J, Damanafshan A, Huveneers S, Eringa E, Vogel S . Effective treatment of edema and endothelial barrier dysfunction with imatinib. Circulation. 2012; 126(23):2728-38. DOI: 10.1161/CIRCULATIONAHA.112.134304. View

4.
Melero-Martin J, Khan Z, Picard A, Wu X, Paruchuri S, Bischoff J . In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood. 2007; 109(11):4761-8. DOI: 10.1182/blood-2006-12-062471. View

5.
Watt F . Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos Trans R Soc Lond B Biol Sci. 1998; 353(1370):831-7. PMC: 1692275. DOI: 10.1098/rstb.1998.0247. View